You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency hub →Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency is a rare condition. Also known as MSMD due to complete IL12RB1 deficiency, MSMD due to complete interleukin 12 receptor beta 1 deficiency, Mendelian susceptibility to interleukin 12 receptor beta 1 deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:319552 · OMIM 614891 · ICD-10 D84.8 · GARD 0010984
Start by learning the basics from an authoritative source, find a specialist or center that sees Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, filtered to your area.
Tomeko shows live, recruiting studies for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency from ClinicalTrials.gov on the hub.